ECR Spotlight on: William Schierding
Recent Posts
Spotlight on: Melanie Eckersley-Maslin 25 November 2022
Spotlight on: Jessamy Tiffen 25 July 2022
ECR Spotlight on: Alex Woodworth 16 July 2022
Epigenetics 2022: Four weeks left for poster abstract submissions! 15 July 2022
Emma Whitelaw ECR Publication Award 30 June 2022
Epigenetics 2022 – Meet the speakers 17 June 2022
ECR Spotlight on: Kate Giles 31 May 2022
Spotlight on: Luciano Martelotto 30 May 2022
Epigenetics 2022 speakers announced 20 April 2022
Spotlight on: Hamish King 18 April 2022
ECR Spotlight on: William Schierding 6 April 2022
Spotlight on: Louise Bicknell 14 March 2022
Categories
News (57)
Opportunities (3)
Publications (7)
Spotlight on … (16)
World epi news (2)
Archived news
2022 (12)
2021 (9)
2020 (9)
2019 (1)
2018 (6)
2017 (6)
2016 (6)
2015 (17)
2014 (1)
by AEpiA | Apr 6, 2022 | News, Spotlight on ...
Briefly, can you tell us about your research?
Amongst 3 billion bases of DNA lurks some 10 million points of genetic variation, many of which contribute to disease risk. Around two-thirds of those disease-associated genetic variants are in non-coding regions of the DNA. The connection between non-coding variants and altered gene function is a major challenge, which makes it difficult to understand why this variation is hazardous to our health, leaving genetic diagnosis tricky and early remediation nearly impossible. My research aims to answer the question, “How does non-coding genetic variation impact on the three-dimensional structure of the DNA, leading to gene dysregulation and disease?”
What advice would you give your undergrad self?
I would warn young me about how my career move to NZ would bring me to the BEST place to live and study but it can at times be challenging and costly to keep in touch with US collaborators. St. Louis is -18 hours! Apologies to everyone I’ve lost contact with over the years.
If you want to get in touch with William you can find him on twitter at @SpaceGenome
#ChromatinBiology #3Dgenome #enhancer #epigenetics #AEpiA
Welcome to our first Early Career Researcher (ECR) Spotlight! Each month we will have a short Q&A with one of our outstanding ECR members to learn more about the exciting epigenetics research taking place across Australia and New Zealand.
First up we will be getting to know more about the AEpiA Committee ECR Reps.
This month we’re introducing William Schierding, from the University of Auckland/Liggins Institute. William received the Illumina™ Emerging Researcher Award in 2020 for his work describing how non-coding genetic variants could dysregulate GBA expression in Parkinson’s Disease.
What is your role on the AEpiA Committee?
I am an early career representative on the AEpiA committee, where my role is to broaden epigenetics research experience and expertise in New Zealand.
Dr William Schierding (back centre) with other early career researchers at the Liggins Institute.